CClinicalTrials.gg
Sign In
CompletedNCT05475470new techniqueUpdated Jul 27, 2022

Blade Finger Technique for Safe Laparoscopic Entery

An interventional study of finger-blade technique and Hasson's technique in Laparoscopic Surgery, Operative Surgical Procedure and Insufflation, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-07-27.

Sponsored by Zagazig University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Mar 2020, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
1,005
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

blade-finger technique is a new technique for laparoscopic access which is safe

Read the detailed description

after optaining irb approval and patients consented, they were divided into 3 groups to whom one of the techniques of laparoscopic entery was applied and there was a comparison between these groups

02

Conditions studied

  • Laparoscopic Surgery
  • Operative Surgical Procedure
  • Insufflation
  • Safety Issues

Keywords

  • veress needle
  • Hasson's technique
  • laparoscopic access
  • blade-finger technique
03

In context

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients more than 18 year-old.
  • underwent laparoscopic surgery in general surgery departments in both centers from March, 2020 to May, 2022.

Exclusion criteria

Exclusion Criteria:

  • Patients with one or more previous abdominal surgery (upper, lower or upper and lower midline scars).
  • Patients with distended abdomen due to bowel obstruction.
  • Patients with uncorrected coagulopathy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
1,005 participants (actual)

Study arms

  • Experimental
    group a

    the group we used our new blade-finger technique

    Procedure: finger-blade technique

  • Experimental
    group b

    the group we used Hasson's technique

    Procedure: Hasson's technique

  • Experimental
    group c

    the group we used veress needle technique

    Procedure: veress needle technique

Interventions

  • Procedurefinger-blade technique

    laparoscopic access technique for group a

    Also known as: laparoscopic access technique

  • ProcedureHasson's technique

    laparoscopic access technique for group b

    Also known as: laparoscopic access technique

  • Procedureveress needle technique

    laparoscopic access technique for group c

    Also known as: laparoscopic access technique for group c

06

What researchers measure

Primary outcomes

  1. time needed to access the peritoneal cavity

    the time of the procedure of access

    Time frame: the first 15 minutes of operation

  2. numbers of trials till the good peritoneal access achieved

    number of trials till succeeded peritoneal access

    Time frame: the first 15 minutes of operation

Secondary outcomes

  1. rate of complications

    bleeding, bowel injury

    Time frame: the first 15 minutes of operation

07

Study locations

1 site
  • Zagazig University
    Zagazig, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05475470
Lead sponsor
Zagazig University
Responsible party
Mohamed lotfy (Dr, Zagazig University) — Principal investigator
First posted
Jul 27, 2022
Start date
Mar 20, 2020
Primary completion
May 31, 2022
Completion
May 31, 2022
Last update
Jul 27, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Zagazig University

Start the discussion